Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy

Clinical trial NCT00332163 · COMPLETED

Trial details

NCT number: NCT00332163
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer Skin Rash Skin Toxicities Colon Cancer Colorectal Cancer

Start date: 2006-04-01
Primary completion: 2008-01-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.